From July 1, 2023 to September 30, 2023, the company has repurchased 1,515,753 shares, for $22.38 million. With this, the company has completed the repurchase of 5,569,632 shares, for $86.21 million under the buyback announced on September 8, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.73 USD | +1.03% | +2.01% | +0.55% |
2023 | Saba Capital Master Fund, Ltd Issues a Letter to BlackRock Health Sciences Term Trust | CI |
2023 | BlackRock Health Sciences Term Trust authorizes a Buyback Plan. | CI |
1st Jan change | Capi. | |
---|---|---|
+0.55% | 1.66B | |
+3.74% | 12.61B | |
+5.50% | 9.01B | |
-3.20% | 5.41B | |
+2.44% | 5.25B | |
+5.63% | 5.19B | |
+14.36% | 4.48B | |
+16.67% | 4.44B | |
+1.53% | 4B | |
+1.56% | 3.75B |
- Stock Market
- Equities
- BMEZ Stock
- News BlackRock Health Sciences Term Trust
- Tranche Update on BlackRock Health Sciences Trust's Equity Buyback Plan announced on September 8, 2022.